LUNOVUS Trademark

Trademark Overview

On Monday, July 16, 2018, a trademark application was filed for LUNOVUS with the United States Patent and Trademark Office. The USPTO has given the LUNOVUS trademark a serial number of 88039540. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Friday, November 22, 2019. This trademark is owned by LUNOVUS, LLC. The LUNOVUS trademark is filed in the Advertising, Business and Retail Services category with the following description:

Distributorship services in the field of neutraceuticals, namely, the manufacture and delivery of neutraceuticals to resellers
lunovus

General Information

Serial Number88039540
Word MarkLUNOVUS
Filing DateMonday, July 16, 2018
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateFriday, November 22, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesDistributorship services in the field of neutraceuticals, namely, the manufacture and delivery of neutraceuticals to resellers

Classification Information

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateTuesday, May 7, 2019
Primary Code035
First Use Anywhere DateThursday, June 16, 2016
First Use In Commerce DateThursday, June 16, 2016

Trademark Owner History

Party NameLUNOVUS, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressMorris, AL 35116

Trademark Events

Event DateEvent Description
Friday, November 22, 2019ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Friday, November 22, 2019ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Friday, November 22, 2019ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Tuesday, May 7, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, May 8, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, May 8, 2019NON-FINAL ACTION E-MAILED
Wednesday, May 8, 2019NON-FINAL ACTION WRITTEN
Tuesday, May 7, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, May 7, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, May 7, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, November 9, 2018NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Friday, November 9, 2018EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Friday, November 9, 2018COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY
Friday, November 9, 2018EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
Friday, November 2, 2018ASSIGNED TO EXAMINER
Thursday, July 19, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, July 19, 2018NEW APPLICATION ENTERED IN TRAM

Related Keywords

lunovus neutraceuticals delivery resellers manufacture namely field distributorship services